Protective Effect of Moderate-Intensity Training and MgSo4 Against Lithium-Induced Renal and Oxidative Damages in Rat Kidney
Advanced Biomedical Research · 2026-04 · 15 (1)
DOI: 10.4103/abr.abr_89_24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Biomedical Research, 2026-04. Verfasst von Elham Shoghi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Zahedan University of Medical Sciences, Zahedan, Iran. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Lithium (Li), as the first line of treatment in bipolar disorder, causes damage to many biological systems, including the kidneys, through the induction of oxidative stress. Magnesium sulfate (MgSo 4 ) and moderate-intensity training (MIT) can diminish the injury caused by Li due to reducing oxidative stress. In this study, we explore the effects of these two factors on Li-induced renal damage. Materials and Methods: Seventy-two male rats were divided into 12 groups: control, MgSo 4 80 mg/kg/day/ip, MIT, MgSo 4 + MIT, Li10 mg/kg/day/ip, Li10 + MgSo 4 , Li10 + MIT, Li10 + MgSo 4 + MIT, Li40 mg/kg/day/ip, Li40 + MgSo 4 , Li40 + MIT, and Li40 + MgSo 4 + MIT. All animals were under the exercise protocol for 6 weeks and received the drugs daily. A blood sample was obtained from the heart to measure blood urea of nitrogen (BUN) and creatinine (Cr). The right kidney was excised and homogenized to measure malondialdehyde (MDA), nitrite, total antioxidant capacity (TAC), superoxide dismutase (SOD), and glutathione peroxidase (GPx), and the left kidneys were placed in 10% formalin to be referred to the laboratory for pathological investigations.
Results
A significant increase in the serum levels of BUN and Cr in the Li40 mg/kg group in comparison with the control group indicates kidney tissue damage, which improved after administration of MgSo 4 and MIT. Treatment with Li10 mg/kg and Li40 mg/kg decreased the TAC, SOD, and GPx and increased the MDA in kidney tissue significantly, which improved after administration of MgSo 4 and MIT in comparison with the Li10 and Li40 groups.
Conclusion
The findings of this study indicated that exercise and MgSo 4 reduced the nephrotoxicity caused by Li via reducing oxidative stress.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physiology, Zahedan University of Medical Sciences, Zahedan, Iran.
- Department of Pathology, Zahedan University of Medical Sciences, Zahedan, Iran.
- Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
- Department of Medical English, Zahedan University of Medical Sciences, Iran.
- Department of Pharmaciligy, Zahedan University of Medical Sciences, Zahedan, Iran.
- Department of Nephrology, Geisinger Medical Center, Danville, Pennsylvania, USA.
Zitieren
APA
Shoghi, E., Miri, S., Nekhat, Z., Niazi, A. A., Hashemi, R., Niyazi, P., Nakhaie, H., Bagheri, H., Vahedi, M. M., Shahraki, E., Bojani, M. Z., Maghool, F., & Safari, T. (2026). Protective Effect of Moderate-Intensity Training and MgSo4 Against Lithium-Induced Renal and Oxidative Damages in Rat Kidney. Advanced Biomedical Research, 15(1). https://doi.org/10.4103/abr.abr_89_24
Vancouver
Shoghi E, Miri S, Nekhat Z, Niazi AA, Hashemi R, Niyazi P, et al. Protective Effect of Moderate-Intensity Training and MgSo4 Against Lithium-Induced Renal and Oxidative Damages in Rat Kidney. Advanced Biomedical Research. 2026;15(1). doi:10.4103/abr.abr_89_24
BibTeX
@article{Shoghi2026,
author = {Shoghi, Elham and Miri, Saideh and Nekhat, Zahra and Niazi, Abbas Ali and Hashemi, Rana and Niyazi, Parsa and Nakhaie, Hossein and Bagheri, Hossein and Vahedi, Mohamad Mahdi and Shahraki, Elham and Bojani, Meysam Zeinali and Maghool, Fatemeh and Safari, Tahereh},
title = {Protective Effect of Moderate-Intensity Training and MgSo4 Against Lithium-Induced Renal and Oxidative Damages in Rat Kidney},
journal = {Advanced Biomedical Research},
year = {2026},
volume = {15},
number = {1},
doi = {10.4103/abr.abr_89_24}
}
EUVIMED